Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2023 Mar;6(2):e402.
doi: 10.1002/edm2.402. Epub 2023 Jan 6.

A clinical trial about effects of prebiotic and probiotic supplementation on weight loss, psychological profile and metabolic parameters in obese subjects

Rym Ben Othman  1 , Nadia Ben Amor  1 , Faten Mahjoub  1 , Olfa Berriche  1 , Chaima El Ghali  1 , Amel Gamoudi  1 , Henda Jamoussi  1
Affiliations
Clinical Trial

A clinical trial about effects of prebiotic and probiotic supplementation on weight loss, psychological profile and metabolic parameters in obese subjects

Rym Ben Othman et al. Endocrinol Diabetes Metab. 2023 Mar.

Abstract

Introduction: The management of obesity is difficult with many failures of lifestyle measures, hence the need to broaden the range of treatments prescribed. The aim of our work was to study the influence of pre and probiotics on weight loss psychological profile and metabolic parameters in obese patients.

Methods: It is a clinical trial involving 45 obese patients, recruited from the Obesity Unit of the National Institute of Nutrition between March and August 2022 divided into three groups: diet only (low-carbohydrate and reduced energy diet), prebiotics (30 g of carob/day) and probiotics (one tablet containing Bifidobacterium longum, Lactobacillus helveticus, Lactococcus lactis, Streptococcus thermophilus/day). The three groups were matched for age, sex and BMI. Patients were seen after 1 month from the intervention. Anthropometric measures, biological parameters, dietary survey and psychological scores were performed.

Results: The average age of our population was 48.73 ± 7.7 years, with a female predominance. All three groups showed a significant decrease in weight, BMI and waist circumference with p < .05. Only the prebiotic and probiotic group showed a significant decrease in fat mass (p = .001) and a significant increase in muscle strength with p = .008 and .004, but the differences were not significant between the three groups. Our results showed also a significant decrease in insulinemia and HOMA-IR in the prebiotic group compared to the diet-alone group (p = .03; p = .012) and the probiotic group showed a significant decrease in fasting blood glucose compared to the diet alone group (p = .02). A significant improvement in sleep quality was noted in the prebiotic group (p = .02), with a significant decrease in depression, anxiety and stress in all three groups.

Conclusions: The prescription of prebiotics and probiotics with the lifestyle measures seems interesting for the management of obesity especially if it is sarcopenic, in addition to the improvement of metabolic parameters and obesity-related psychiatric disorders.

Keywords: obesity; prebiotics; probiotics; weight loss.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. World Health Organisation . Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1‐253. - PubMed
    1. Rapport de l'enquête national THES‐2016 ‐ Ministère de la santé publique [Internet]. [cité 6 sept 2022]. Disponible sur. http://www.santetunisie.rns.tn/fr/toutes‐les‐actualites/912‐rapport‐de‐l...
    1. Dao MC, Clément K. Gut microbiota and obesity: concepts relevant to clinical care. Eur J Intern Med. 2018;48:18‐24. - PubMed
    1. Brahe LK, Astrup A, Larsen LH. Can we prevent obesity‐related metabolic diseases by dietary modulation of the gut microbiota? Adv Nutr. 2016;7(1):90‐101. - PMC - PubMed
    1. Bakker GJ, Meijnikman AS, Scheithauer TP, et al. Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesity. Obes Sci Pract. 2022;8(1):56‐65. - PMC - PubMed

Publication types